| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.3M | -2.5% |
| Cost of Revenue | $6.8M | +10.5% |
| Gross Profit | $469K | -64.2% |
| R&D Expense | $1.5M | -15.5% |
| SG&A Expense | $7.8M | -17.6% |
| Operating Income | -$11.0M | +4.0% |
| Net Income | -$10.8M | +4.2% |
| EPS (Basic) | -$1.39 | +10.9% |
| EPS (Diluted) | -$1.39 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $403K | -72.4% |
| Inventory | $605K | -60.3% |
| Current Assets | $8.1M | +29.3% |
| Total Assets | $35.0M | +172.2% |
| Current Liabilities | $16.1M | +395.5% |
| Total Liabilities | $32.7M | +337.4% |
| Stockholders' Equity | $2.3M | -57.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | +60.1% |
| Capital Expenditures | $1.8M | +268.8% |
| Investing Cash Flow | -$1.8M | -68.3% |
| Financing Cash Flow | $9.2M | -18.0% |
| Free Cash Flow | -$5.3M | +42.4% |
| +10.9% |